Scarica l'app Stockscreener
3.09
1.28%
-0.04
Pre-mercato:
3.24
0.15
+4.85%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Embecta Corp Borsa (EMBC) Ultime notizie
Embecta Corp. Announces Appointment of Nimish Muzumdar to Senior Vice President and President, North America, Effective June 15, 2026 - marketscreener.com
Embecta Corp. Appoints Nimish Muzumdar as Senior Vice President and President, North America - Quiver Quantitative
New embecta North America chief once ran a $1B generics division - Stock Titan
EMBC Investors Have Opportunity to Join Embecta Corp. Fraud Investigation with the Schall Law Firm - The AI Journal
EMBC News | EMBECTA CORP (NASDAQ:EMBC) - ChartMill
Packaging update regarding BD pen needles and insulin syringes - retailpharmacymagazine.com.au
EMBC Q1 2026 Earnings: EPS Miss Sends Shares LowerEarnings Sentiment Score - newsline.com
EMBC Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesEPS Surprise History - newsline.com
EMBC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Embecta Corp. (EMBC) Q1 2026 Earnings: EPS Miss Weighs on Sentiment as Cost Headwinds PersistCash Flow Report - newsline.com
Mizuho cuts Embecta stock price target on weak US sales performance - Investing.com
River Road Asset Management, LLC Sells Out Position in Embecta C - GuruFocus
Embecta Corp. (EMBC) grants 30,000 shares to VP, Chief Accounting Officer - Stock Titan
embecta to Participate in Investor Events - The Manila Times
Embecta to Participate in Investor Events - marketscreener.com
EMBC Technical Analysis & Stock Price Forecast - Intellectia AI
Embecta faces US reset as CEO bets on GLP-1, Owen Mumford diversification - MSN
EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp. - GlobeNewswire
Bragar Eagel & Squire, P.C. is Investigating Embecta Corp. - GlobeNewswire
Embecta Corp. (EMBC) Shows Modest Rebound as Shares Trade Near Support LevelsMoney Flow - thelegaladvocate.com
Law firm investigates Embecta after shares plunge 58% on weak Q2 results and lowered guidance - Pluang
Embecta (NYSE: EMBC) Schedule 13G/A — River Road reports 0 shares - Stock Titan
Embecta To Go Ex-Dividend On May 28th, 2026 With 0.01 USD Dividend Per Share - Moomoo
EMBC - Finviz
Embecta Corp. (EMBC) Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains UndisclosedEPS Guidance Update - thelegaladvocate.com
EMBC PE Ratio & Valuation, Is EMBC Overvalued - Intellectia AI
Embecta acquires Owen Mumford for $172.6m - MSN
Embecta (EMBC) Faces Target Cut Amid Weakening Medtech SentimentAnalyst Drop Coverage - newsline.com
What Triggered Embecta's Recent Stock Plunge and Analyst Downgrades - Kavout
Embecta (EMBC) Hit With A Sharp Target Cut As Medtech Sentiment Weakens - Insider Monkey
Why Embecta stock plummeted today - MSN
Embecta Corp. (EMBC) Q1 2026 Earnings: EPS Misses Expectations as Revenue Data Remains Unavailable - newsline.com
Embecta Corp. (EMBC) Holds Steady at $3.32 as Traders Await Clear DirectionRounding Bottom - thelegaladvocate.com
Embecta Corp. (EMBC) Stalls Near Support Amid Low-Volume TradingVolume Oscillator - newsline.com
EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Carroll County Mirror-Democrat
Embecta closes $200M Owen Mumford acquisition - NJBIZ
Embecta Corp. (EMBC) Securities Fraud InvestigationLevi & Korsinsky - PR Newswire
Embecta Corp stock (US29082K1051): analyst price cut and sliding share price put diabetes specialist - AD HOC NEWS
EMBC Maintained by B of A Securities -- Price Target Lowered to $3.00 - GuruFocus
Forvis Mazars advises on sale of Owen Mumford to US-listed Embecta - Accountancy Today
Embecta Price Target Cut to $3.00/Share From $11.00 by B of A Securities - Moomoo
Embecta closes Owen Mumford acquisition for up to $201M - MedTech Dive
Embecta Is Maintained at Underperform by B of A Securities - Moomoo
Embecta completes Owen Mumford acquisition - Drug Delivery Business
BofA Securities Adjusts Price Target on Embecta to $3 From $11 - Moomoo
1.68%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):